tiprankstipranks
Akebia Therapeutics Secures Supply Agreement for Vafseo
PremiumCompany AnnouncementsAkebia Therapeutics Secures Supply Agreement for Vafseo
1M ago
Akebia signs commercial supply contract with dialysis organization
Premium
The Fly
Akebia signs commercial supply contract with dialysis organization
1M ago
Akebia: CMS grants TDAPA reimbursement for Vafseo starting January 1, 2025
Premium
The Fly
Akebia: CMS grants TDAPA reimbursement for Vafseo starting January 1, 2025
1M ago
Is AKBA a Buy, Before Earnings?
PremiumPre-EarningsIs AKBA a Buy, Before Earnings?
4M ago
Akebia Therapeutics Ends Licensing Deal, Commits to Repayment Plan
Premium
Company Announcements
Akebia Therapeutics Ends Licensing Deal, Commits to Repayment Plan
4M ago
Akebia, CSL Vifor enter termination agreement of the Vafseo license agreement
Premium
The Fly
Akebia, CSL Vifor enter termination agreement of the Vafseo license agreement
4M ago
Akebia Therapeutics (AKBA) Q1 Earnings Cheat Sheet
PremiumPre-EarningsAkebia Therapeutics (AKBA) Q1 Earnings Cheat Sheet
7M ago
Akebia price target raised to $6 from $5 at H.C. Wainwright
Premium
The Fly
Akebia price target raised to $6 from $5 at H.C. Wainwright
8M ago
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100